10 Nov 20
News
10 Nov 20
Transformational year for Biocomposites
STIMULAN - the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft-tissue, appointed new President, Biocomposites Inc., USA and significantly extended global distributor coverage
Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use…...
18 Jun 20
News
18 Jun 20
Biocomposites announces STIMULAN® products added to NHS Supply Chain
STIMULAN is the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue
Keele, UK,  18 June 2020 – Biocomposites, an international medical devices company that engineers, manufactures and…...
23 Apr 20
News
23 Apr 20
Biocomposites announces new CE Mark for STIMULAN®
First calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue
Keele, UK, 23 April 2020 – Biocomposites, an international medical devices company that engineers, manufactures and…...
Pioneering calcium compounds

Innovation is at the very heart of what we do, resulting in over 100 grants and registrations.

Musculoskeletal infection

Growth of antibiotic-resistant biofilms continues to outpace the development of new antibiotics.

Singular focus

Deep expertise and singular focus on calcium compound medical devices

Dedicated to quality

Manufacturing, processing, testing and distribution are all handled in-house

Your specialty

Access case studies, clinical and pre-clinical papers for musculoskeletal infection, trauma and spine to see how we are innovating across a wide range of clinical applications to help surgeons and their patients.

Musculoskeletal infections

Musculoskeletal infections, including infected non-unions, osteomyelitis and periprosthetic joint infections, are one of the biggest healthcare challenges of the 21st century.

As the rapid growth of antibiotic-resistant strains and biofilms continues to outpace the development of new antibiotics and antibiotic strategies, care delivery is becoming increasingly challenging and complicated.

Trauma

Bone and joint trauma, such as fractures and dislocations, are common and vary in severity from single fractures to multiple, life-threatening musculoskeletal injuries.

The most clinically challenging of these for the surgeon, and those that have the most socioeconomic burden, are open fractures. These often involve damage to the surrounding soft tissue, resulting in complications such as tissue and deep bone infection or long-term non-union.

Why Biocomposites?

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 30 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

  • Singular focus
  • Proprietary technology
  • Dedicated to quality
Learn more